Department of Medicine III, Universitätsklinikum Dresden, Dresden, Germany.
Center for Healthy Aging, Universitätsklinikum Dresden, Dresden, Germany.
Thyroid. 2020 Feb;30(2):329-342. doi: 10.1089/thy.2019.0271. Epub 2020 Jan 31.
Bone is an important target of thyroid hormones (THs), which require transport into target cells to exert their actions. Recently, the TH-specific monocarboxylate transporter 8 (Mct8) was reported as a regulator of bone mass in male mice. However, its global deletion leads to high 3,3',5-L-triiodothyronine (T3) serum concentrations that may mask direct effects of Mct8-deficiency on bone. In this study, we assessed the bone cell intrinsic function of Mct8 and using conditional -knockout lines specifically targeting osteoclast and osteoblast progenitors, as well as mature osteoblasts and osteocytes. Twelve-week-old male mice with a global Mct8-deficiency or a conditional -knockout in osteoclast precursors, osteoprogenitors, or mature osteoblasts/osteocytes were analyzed regarding their bone microarchitecture, turnover, and strength. Furthermore, studies were conducted to investigate the role of Mct8 in bone cell differentiation and functionality, as well as TH uptake. Global -knockout mice demonstrated 1.7-fold higher T3 serum concentrations and trabecular bone loss (-28%) likely due to an increased bone turnover as shown by increased osteoblast (+45%) and osteoclast numbers (+41%). However, cortical bone mineral density was increased. cultures of bone marrow-derived osteoblasts and osteoclasts revealed highest expression of in mature bone cells. In addition, Mct8-deficiency resulted in a lower mRNA expression of osteoblast and osteoclast differentiation markers, as well as a reduced mineralization capacity and osteoclast numbers, respectively, indicating a bone cell intrinsic role of Mct8. In fact, conditional -knockout and inhibition of Mct8 in osteoblasts led to an attenuated T3 uptake . , osteoprogenitor-specific -knockout enhanced trabecular bone volume (+16%) with osteoblast numbers being increased 3.7 fold. Interestingly, Mct8-deficiency in osteoprogenitors and late osteoblasts/osteocytes both resulted in cortical bone loss. Finally, -deletion in osteoclast progenitors increased trabecular bone volume (+20%) due to reduced osteoclast numbers (-32%), whereas osteoblast numbers were enhanced (+25%). This study confirms that high systemic T3 in global knockout mice masks the direct effect of Mct8. Moreover, it identifies Mct8 as a critical regulator of trabecular vs. cortical bone by regulating T3 uptake and highlights its cell intrinsic role in osteoclast and osteoblast progenitors.
骨骼是甲状腺激素(THs)的重要靶标,TH 需要进入靶细胞才能发挥作用。最近,TH 特异性单羧酸转运蛋白 8(Mct8)被报道为雄性小鼠骨量的调节剂。然而,其全局缺失会导致高 3,3',5-L-三碘甲状腺原氨酸(T3)血清浓度,这可能掩盖 Mct8 缺乏对骨骼的直接影响。在这项研究中,我们使用专门针对破骨细胞前体、成骨细胞祖细胞以及成熟成骨细胞和骨细胞的条件性 - 敲除系,评估了 Mct8 的骨细胞内在功能。分析了 12 周龄的全身性 Mct8 缺陷或破骨细胞前体、成骨细胞祖细胞或成熟成骨细胞/骨细胞中条件性 - 敲除的雄性小鼠的骨微结构、周转率和强度。此外,进行了研究以调查 Mct8 在骨细胞分化和功能以及 TH 摄取中的作用。全身性 - 敲除小鼠的 T3 血清浓度高 1.7 倍,小梁骨丢失(-28%)可能是由于骨转换增加,表现为成骨细胞(+45%)和破骨细胞数量(+41%)增加。然而,皮质骨密度增加。骨髓源性成骨细胞和破骨细胞的培养表明成熟骨细胞中 表达最高。此外,Mct8 缺陷导致成骨细胞和破骨细胞分化标志物的 mRNA 表达降低,以及矿化能力和破骨细胞数量分别降低,表明 Mct8 具有骨细胞内在作用。事实上,成骨细胞中条件性 - 敲除和 Mct8 抑制导致 T3 摄取减少。有趣的是,成骨细胞特异性 - 敲除导致小梁骨体积增加(+16%),成骨细胞数量增加 3.7 倍。有趣的是,成骨细胞前体和成骨细胞/骨细胞中的 Mct8 缺陷均导致皮质骨丢失。最后,破骨细胞前体中的 - 缺失由于破骨细胞数量减少(-32%)而导致小梁骨体积增加(+20%),而成骨细胞数量增加(+25%)。这项研究证实,全身性敲除小鼠中的高全身性 T3 掩盖了 Mct8 的直接作用。此外,它将 Mct8 确定为通过调节 T3 摄取来调节骨小梁与皮质骨的关键调节剂,并突出了其在破骨细胞和成骨细胞祖细胞中的细胞内在作用。